Lumen Technologies to shift stock, Qwest notes listing to Nasdaq

Lumen Technologies to shift stock, Qwest notes listing to Nasdaq
Lumen shifts to Nasdaq

Lumen Technologies is repositioning its market presence as it expands networking services for artificial intelligence customers. The company plans to move its common stock and two Qwest Corp notes from the New York Stock Exchange to Nasdaq, while keeping its operations, financial condition and reporting obligations unchanged.

Highlights

  • Lumen Technologies will transfer its common stock and two Qwest Corp notes from NYSE to Nasdaq, effective October 6, keeping ticker symbols LUMN, CTGG, and CTHH.
  • The listing transfer does not affect Lumen's operations, financial condition, or reporting obligations, and requires no action from shareholders.
  • Lumen's move to Nasdaq aligns with its strategy to emphasize network services for AI-related demand and positions it among technology-focused peers in the telecom sector.

Listing transfer timeline and scope

As reported by Reuters, Lumen said the transfer covers its common stock and two Qwest Corp notes, as the company argues Nasdaq is a better fit for its technology-focused business. Chief Executive Kate Johnson said Nasdaq is the right home for the company's next chapter as it builds out that strategy.

Lumen expects its common shares and Qwest notes to be delisted from the NYSE after the market closes on Oct. 5. The securities are expected to begin trading on Nasdaq at the market open on Oct. 6, subject to customary closing conditions.

The company said its common stock is expected to keep the ticker symbol LUMN. The Qwest notes are expected to continue trading under the symbols CTGG and CTHH.

Lumen and Qwest have applied for Nasdaq listings and plan to file a Form 25 with the U.S. Securities and Exchange Commission to remove the securities from the NYSE list.

Implications for investors and telecom sector positioning

The listing change does not affect Lumen's operations, financial condition or reporting obligations, according to the company. Shareholders also do not need to take any action as part of the transfer.

The move aligns Lumen more closely with an exchange associated with technology issuers at a time when the company is emphasizing network services for AI-related demand. For the telecom and infrastructure sector, the shift highlights how legacy communications groups are trying to frame themselves around digital capacity and enterprise connectivity growth.

Our earlier article on biotech IPO momentum highlighted ADARx Pharmaceuticals’ upsized U.S. IPO and its planned Nasdaq debut under the ticker ADRX. We noted that investor demand has remained relatively strong for healthcare listings, with large financings and continued filings even as the broader IPO market stays selective.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.